Related Experiment Video
Updated: Oct 26, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts?
Naga Dharmavaram1, Timothy Hess1,2, Heather Jaeger3
1Department of Medicine University of Wisconsin Hospital and Clinics Madison WI.
Insights
Heart transplant survival has improved despite an increase in donor offers and a decrease in the transplant rate. Accepting donors with higher risks, such as from drug overdose or hepatitis C, may further increase transplants without harming short-term outcomes.
Area of Science:
- Cardiology
- Transplant Surgery
- Public Health
Background:
- The number of heart transplants has risen, but the reasons and impact on recipient survival are unclear.
- An increase in donor offers has not translated to a higher heart transplant rate.
- Donors in recent years are older and have more comorbidities, including drug overdose and hepatitis C positivity.
Purpose of the Study:
- To investigate whether the increase in heart transplants is solely due to donor availability.
- To assess the impact of changing donor characteristics on recipient survival.
- To explore strategies for increasing heart transplant numbers.
Main Methods:
- Comparative analysis of donor and recipient characteristics from 2003-2017.
- Utilized Cox models to evaluate 30-day and 1-year recipient mortality risk.
- Examined data from 10,869 (2003-2007), 11,654 (2008-2012), and 14,556 (2013-2017) heart transplants.
Main Results:
- The ratio of hearts transplanted to available donors declined from 2013-2017.
- Donors were older, heavier, more hypertensive, diabetic, and had higher rates of illicit drug abuse.
- Recipient survival improved, with a 15% lower 30-day and 21% lower 1-year mortality risk in 2013-2017 compared to 2003-2007.
Conclusions:
- Despite increased donor offers and utilization of higher-risk donors, heart transplant recipient survival has improved.
- Broader acceptance of donors from drug overdose and hepatitis C positive cases could increase transplant numbers.
- Expanding donor criteria may enhance transplant rates without compromising short-term patient outcomes.
Abstract:
Background It is unclear whether the recent increase in the number of heart transplants performed annually in the United States is only because of higher availability of donors and if it affected recipients' survival. Methods and Results We examined characteristics of donors and recipients from 2008 to 2012 (n=11 654) and 2013 to 2017 (n=14 556) and compared them with 2003 to 2007 (n=10 869). Cox models examined 30-day and 1-year risk of recipients' death post transplant. From 2013 to 2017, there was an increase in the number of transplanted hearts and number of donor offers but an overall decline in the ratio of hearts transplanted to available donors. Donors between 2013 and 2017 were older, heavier, more hypertensive, diabetic, and likely to have abused illicit drugs compared with previous years. Drug overdose and hepatitis C positive donors were additional contributors to donor risk in recent years. In Cox models, risk of death post transplant between 2013 and 2017 was 15% lower at 30 days (hazard ratio [HR] 0.85; 95% CI, 0.74-0.98) and 21% lower at 1 year (HR, 0.79; 95% CI, 0.73-0.87) and between 2008 and 2012 was 9% lower at 30 days (HR, 0.91; 95% CI, 0.79-1.05) and 14% lower at 1 year (HR, 0.86; 95% CI, 0.79-0.94) compared with 2003 to 2007. Conclusions Despite a substantial increase in heart donor offers in recent years, the ratio of transplants performed to available donors has decreased. Even though hearts from donors who are older, more hypertensive, and have diabetes mellitus are being used, overall recipient survival continues to improve. Broader acceptance of drug overdose and hepatitis C positive donors may increase the number and percentage of heart transplants further without jeopardizing short-term outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

